@ShahidNShah
A cutting edge multi-purpose platform for quantitative diagnostic immunoassays that opens the way to central lab performance at the point-of-need, using chemiluminescence detection technology.
MeMed Key™ is being developed with three main benefits in mind:
Performance:
MeMed Key™ provides accuracy similar to large central lab immunoassay platforms in a miniaturized and point-of-need format.
MeMed Key™ cartridges allow simultaneous measurements of up to four different analytes.
Convenience:
Due to its miniaturized chemiluminescence detection technology, MeMed Key™ analyzes low volumes of various specimen types including serum, plasma, capillary blood, urine and nasal.
MeMed Key™ has an easy-to-use Graphical User Interface (GUI) and sample-to-answer workflow, making it suitable for a non-professional user.
Expandability:
Expandable test menu - MeMed Key™ uses a chemiluminescence-based immunoassay. This format readily enables transitioning a wide range of conventional and novel immunoassays onto the platform.
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2024 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 22, 2024 at 12:50pm